Sinotherapeutics (SHSE:688247) Total Liabilities : ¥152.5 Mil (As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Sinotherapeutics Total Liabilities?

Sinotherapeutics's Total Liabilities for the quarter that ended in Mar. 2024 was ¥152.5 Mil.

Sinotherapeutics's quarterly Total Liabilities declined from Sep. 2023 (¥159.73 Mil) to Dec. 2023 (¥151.36 Mil) but then increased from Dec. 2023 (¥151.36 Mil) to Mar. 2024 (¥152.47 Mil).

Sinotherapeutics's annual Total Liabilities declined from Dec. 2021 (¥160.62 Mil) to Dec. 2022 (¥155.05 Mil) and declined from Dec. 2022 (¥155.05 Mil) to Dec. 2023 (¥151.36 Mil).

Sinotherapeutics Total Liabilities Historical Data

The historical data trend for Sinotherapeutics's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sinotherapeutics Total Liabilities Chart

Sinotherapeutics Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

89.51

180.76

160.62

155.05

151.36

Sinotherapeutics Quarterly Data
	Dec18	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial												143.90	175.26	159.73	151.36	152.47

Sinotherapeutics Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Sinotherapeutics's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	90.717	+	(0.022	+	60.622
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	151.4

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	1361.62	-	1210.259
	=	151.4

Sinotherapeutics's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	95.14	+	(0.007	+	57.322
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	152.5

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	1353.289	-	1200.82
	=	152.5

Sinotherapeutics Total Liabilities Related Terms

Thank you for viewing the detailed overview of Sinotherapeutics's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Sinotherapeutics (SHSE:688247) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sinotherapeutics Inc (SHSE:688247) » Definitions » Total Liabilities

Traded in Other Exchanges

N/A

Address

No. 515 Huanke Road, Room 205 and 207, Pilot Free Trade Zone, Shanghai, CHN, 201203

Website

http://www.sinotherapeutics.com

Sinotherapeutics Inc is engaged in the research and development, production and sales of generic drugs and CRO services.

Sinotherapeutics (SHSE:688247) Headlines

No Headlines